Mechanically, sorafenib induces HCC cell apoptosis through activation of GSK-3β and subsequent proteasomal degradation of MCL-1, but these effects are inhibited by bilirubin (Figure 7). This evidence concerns the gene MCL1 and hepatocellular carcinoma.